ATE428721T1 - Verfahren zur herstellung von wachstumshormon und antagonisten davon mit geringeren konzentrationen an isoformen verunreinigungen davon - Google Patents
Verfahren zur herstellung von wachstumshormon und antagonisten davon mit geringeren konzentrationen an isoformen verunreinigungen davonInfo
- Publication number
- ATE428721T1 ATE428721T1 AT03799266T AT03799266T ATE428721T1 AT E428721 T1 ATE428721 T1 AT E428721T1 AT 03799266 T AT03799266 T AT 03799266T AT 03799266 T AT03799266 T AT 03799266T AT E428721 T1 ATE428721 T1 AT E428721T1
- Authority
- AT
- Austria
- Prior art keywords
- growth hormone
- isoform impurities
- antagonists
- impurities
- isoform
- Prior art date
Links
- 102000001708 Protein Isoforms Human genes 0.000 title abstract 6
- 108010029485 Protein Isoforms Proteins 0.000 title abstract 6
- 239000012535 impurity Substances 0.000 title abstract 6
- 108010051696 Growth Hormone Proteins 0.000 title abstract 3
- 102000018997 Growth Hormone Human genes 0.000 title abstract 3
- 239000000122 growth hormone Substances 0.000 title abstract 3
- 239000005557 antagonist Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000010188 recombinant method Methods 0.000 abstract 3
- 229940122853 Growth hormone antagonist Drugs 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 108700037519 pegvisomant Proteins 0.000 abstract 1
- 229960002995 pegvisomant Drugs 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40655302P | 2002-08-28 | 2002-08-28 | |
| US10/646,798 US20040048315A1 (en) | 2002-08-28 | 2003-08-25 | Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof |
| PCT/US2003/026498 WO2004031213A1 (en) | 2002-08-28 | 2003-08-26 | Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE428721T1 true ATE428721T1 (de) | 2009-05-15 |
Family
ID=31997673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03799266T ATE428721T1 (de) | 2002-08-28 | 2003-08-26 | Verfahren zur herstellung von wachstumshormon und antagonisten davon mit geringeren konzentrationen an isoformen verunreinigungen davon |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20040048315A1 (de) |
| EP (1) | EP1546185B1 (de) |
| JP (1) | JP4312154B2 (de) |
| KR (1) | KR101176588B1 (de) |
| AT (1) | ATE428721T1 (de) |
| AU (1) | AU2003260045B2 (de) |
| BR (1) | BRPI0313829B1 (de) |
| CA (1) | CA2497146C (de) |
| CY (1) | CY1109167T1 (de) |
| DE (1) | DE60327228D1 (de) |
| DK (1) | DK1546185T3 (de) |
| ES (1) | ES2323586T3 (de) |
| IL (1) | IL167121A (de) |
| MX (1) | MXPA05002359A (de) |
| PL (1) | PL211502B1 (de) |
| PT (1) | PT1546185E (de) |
| RU (1) | RU2337920C2 (de) |
| SI (1) | SI1546185T1 (de) |
| TW (2) | TW200700553A (de) |
| WO (1) | WO2004031213A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040048315A1 (en) | 2002-08-28 | 2004-03-11 | Pharmacia Corporation | Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof |
| EP1833841B1 (de) | 2004-12-29 | 2010-04-07 | Novo Nordisk Health Care AG | Verfahren zur verhinderung der bildung von trisulfidderivaten von polypeptiden |
| US9005926B2 (en) | 2009-10-02 | 2015-04-14 | Biogen Idec Ma Inc. | Methods of preventing and removing trisulfide bonds |
| DK2513135T3 (da) * | 2009-12-18 | 2020-05-18 | Csl Ltd | Fremgangsmåde til oprensning af polypeptider |
| DK2707383T3 (en) | 2011-05-13 | 2018-07-23 | Biogen Ma Inc | PROCEDURES FOR PREVENTION AND REMOVAL OF TRISULPHIDE BINDINGS |
| RU2014108241A (ru) | 2011-08-25 | 2015-09-27 | Ф.Хоффманн-Ля Рош Аг | Способ катион- и анионобменной хроматографии |
| MY198629A (en) | 2014-07-24 | 2023-09-11 | Genentech Inc | Methods of conjugating an agent to a thiol moiety in a protein that contains at least one trisulfide bond |
| MX2018013683A (es) * | 2016-05-10 | 2019-06-17 | Genentech Inc | Métodos para disminuir los enlaces de trisulfuro durante la producción recombinante de polipéptidos. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5153265A (en) | 1988-01-20 | 1992-10-06 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
| US5969109A (en) | 1990-02-28 | 1999-10-19 | Bona; Constantin | Chimeric antibodies comprising antigen binding sites and B and T cell epitopes |
| DK44593D0 (da) * | 1993-04-20 | 1993-04-20 | Novo Nordisk As | Fremgangsmaade til fremstilling af et polypeptid |
| ZA955789B (en) * | 1994-07-15 | 1996-03-11 | Novo Nordisk As | A method of converting a hydrophobic derivative of a polypeptide into the native form |
| JP3628333B2 (ja) * | 1995-09-21 | 2005-03-09 | ジェネンテック インコーポレーテッド | ヒト成長ホルモン変異体 |
| SE9802454D0 (sv) * | 1998-07-08 | 1998-07-08 | Pharmacia & Upjohn Ab | Production of peptides |
| AR026743A1 (es) * | 1999-12-09 | 2003-02-26 | Pharmacia Ab | Produccion de peptidos |
| US7229789B1 (en) | 2001-01-19 | 2007-06-12 | N.V. Organon | Methods and compositions for extracting proteins from cells |
| US20040048315A1 (en) | 2002-08-28 | 2004-03-11 | Pharmacia Corporation | Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof |
| US7470779B2 (en) * | 2002-09-20 | 2008-12-30 | Pfizer Inc. | Process for decreasing aggregate levels of pegylated protein |
-
2003
- 2003-08-25 US US10/646,798 patent/US20040048315A1/en not_active Abandoned
- 2003-08-26 PT PT03799266T patent/PT1546185E/pt unknown
- 2003-08-26 ES ES03799266T patent/ES2323586T3/es not_active Expired - Lifetime
- 2003-08-26 AT AT03799266T patent/ATE428721T1/de active
- 2003-08-26 MX MXPA05002359A patent/MXPA05002359A/es active IP Right Grant
- 2003-08-26 WO PCT/US2003/026498 patent/WO2004031213A1/en not_active Ceased
- 2003-08-26 BR BRPI0313829-1A patent/BRPI0313829B1/pt not_active IP Right Cessation
- 2003-08-26 PL PL374917A patent/PL211502B1/pl unknown
- 2003-08-26 EP EP03799266A patent/EP1546185B1/de not_active Expired - Lifetime
- 2003-08-26 RU RU2005109388/13A patent/RU2337920C2/ru active
- 2003-08-26 KR KR1020057003458A patent/KR101176588B1/ko not_active Expired - Fee Related
- 2003-08-26 SI SI200331584T patent/SI1546185T1/sl unknown
- 2003-08-26 AU AU2003260045A patent/AU2003260045B2/en not_active Expired
- 2003-08-26 CA CA2497146A patent/CA2497146C/en not_active Expired - Fee Related
- 2003-08-26 DE DE60327228T patent/DE60327228D1/de not_active Expired - Lifetime
- 2003-08-26 DK DK03799266T patent/DK1546185T3/da active
- 2003-08-26 JP JP2004541486A patent/JP4312154B2/ja not_active Expired - Lifetime
- 2003-08-28 TW TW095130368A patent/TW200700553A/zh unknown
- 2003-08-28 TW TW092123686A patent/TWI289603B/zh not_active IP Right Cessation
-
2005
- 2005-02-27 IL IL167121A patent/IL167121A/en unknown
-
2009
- 2009-03-17 US US12/405,857 patent/US8148331B2/en not_active Expired - Fee Related
- 2009-06-24 CY CY20091100660T patent/CY1109167T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200407428A (en) | 2004-05-16 |
| EP1546185A1 (de) | 2005-06-29 |
| CA2497146A1 (en) | 2004-04-15 |
| DK1546185T3 (da) | 2009-06-22 |
| JP2006517091A (ja) | 2006-07-20 |
| PL211502B1 (pl) | 2012-05-31 |
| KR101176588B1 (ko) | 2012-08-23 |
| US20040048315A1 (en) | 2004-03-11 |
| EP1546185A4 (de) | 2006-09-06 |
| TWI289603B (en) | 2007-11-11 |
| BRPI0313829B1 (pt) | 2021-10-26 |
| CA2497146C (en) | 2012-05-22 |
| US8148331B2 (en) | 2012-04-03 |
| HK1077074A1 (en) | 2006-02-03 |
| PL374917A1 (en) | 2005-11-14 |
| BR0313829A (pt) | 2005-07-26 |
| IL167121A (en) | 2010-11-30 |
| RU2337920C2 (ru) | 2008-11-10 |
| PT1546185E (pt) | 2009-07-14 |
| SI1546185T1 (sl) | 2009-08-31 |
| AU2003260045A1 (en) | 2004-04-23 |
| WO2004031213A1 (en) | 2004-04-15 |
| DE60327228D1 (de) | 2009-05-28 |
| JP4312154B2 (ja) | 2009-08-12 |
| TW200700553A (en) | 2007-01-01 |
| ES2323586T3 (es) | 2009-07-21 |
| US20100021966A1 (en) | 2010-01-28 |
| RU2005109388A (ru) | 2005-10-27 |
| AU2003260045B2 (en) | 2010-01-07 |
| MXPA05002359A (es) | 2005-07-15 |
| CY1109167T1 (el) | 2014-07-02 |
| KR20050059163A (ko) | 2005-06-17 |
| EP1546185B1 (de) | 2009-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Funk et al. | Expression of the amino-terminal half-molecule of human serum transferrin in cultured cells and characterization of the recombinant protein | |
| MX172600B (es) | , "procedimiento para la produccion de una proteina biologicamente activa | |
| BRPI0410164A (pt) | composições e métodos para preparação de mutantes de glicosilação de hormÈnio do crescimento humano | |
| DE122009000068I2 (de) | Verfahren zur Herstellung von heterologen bispezifischen Antikörpern | |
| ATE466030T1 (de) | Neues screening-verfahren | |
| ATE334998T1 (de) | Verfahren zur herstellung cyclischer peptide | |
| DE3586773D1 (de) | Verfahren zur beseitigung von n-endaminosaeureresten aus eukaryotpolypeptidanlagen und so erzeugte polypeptide. | |
| CY1109167T1 (el) | Μεθοδος για την παρασκευη αυξητικης ορμονης και ανταγωνιστη αυτης εχοντας χαμηλοτερα επιπεδα ισομορφικων προσμειξεων αυτου | |
| AU2001287000A1 (en) | Modified polypeptides stabilized in a desired conformation and methods for producing same | |
| CY1109518T1 (el) | Αναστολεας ενεργοποιητη αυξητικου παραγοντα ηπατοκυτταρων για χρηση σε διαμορφωση αγγειογενεσης και καρδιοαγγειωσης | |
| ATE330003T1 (de) | Rekombinanter stabiler zellklon, seine herstellung und verwendung | |
| ATE537173T1 (de) | Verfahren zur herstellung von cucurbiturilen | |
| ATE515516T1 (de) | Pektin, verfahren zu dessen herstellung, azide eiweissnahrungsmittel mit der verwendung von pektin, sowie verfahren zur herstellung derselben | |
| ATE408016T1 (de) | Verfahren zur herstellung und sekretion modifizierter peptide | |
| IL167538A (en) | A process for reducing the level of the pegilated growth hormone antibody aggregate | |
| DE60040771D1 (de) | Verfahren zur kontrolle der spaltung mit ompt protease | |
| ATE511644T1 (de) | Neues screening-verfahren | |
| ATE319837T1 (de) | Verfahren zur herstellung von rekombinantem trypsin | |
| DE602004014251D1 (de) | Verfahren zur proteinisolierung unteranoxischen bedingungen | |
| ATE529437T1 (de) | Verfahren zur sauerstoff-regulierten produktion von recombinanter staphylokinase | |
| TW200502248A (en) | Process for decreasing aggregate levels of pegylated protein | |
| AR041070A1 (es) | Metodo para la preparacion de hormona de crecimiento y de un antagonista de la misma que contiene niveles reducidos de sus isoformas como impurezas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1546185 Country of ref document: EP |